Schrodinger Inc (SDGR)

10:32 AM

Schrödinger, Inc. (SDGR): Among Top Stocks in Bill Gates’ Portfolio with Huge Upside Potential - Insider Monkey

10:32 AM

09:06 AM

Schrödinger to Announce First Quarter 2025 Financial Results on May 7 - BioSpace

09:06 AM

08:50 AM

Schrödinger to Announce First Quarter 2025 Financial Results on May 7 | SDGR Stock News - GuruFocus

08:50 AM

Apr 21, 2025

3 Momentum Stocks That Could Soar Post-Market Volatility - Investing.com

Apr 21, 2025

Apr 21, 2025

3 Momentum Stocks That Could Soar Post-Market Volatility - MarketBeat

Apr 21, 2025

Apr 18, 2025

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - 01net

Apr 18, 2025

Apr 18, 2025

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SDGR Stock News - GuruFocus

Apr 18, 2025

Apr 17, 2025

Schrödinger (NASDAQ:SDGR) shareholders are up 29% this past week, but still in the red over the last five years - simplywall.st

Apr 17, 2025

Apr 16, 2025

Schrodinger (SDGR) Moves 27.4% Higher: Will This Strength Last? - MSN

Apr 16, 2025

Apr 16, 2025

An Intrinsic Calculation For Schrödinger, Inc. (NASDAQ:SDGR) Suggests It's 26% Undervalued - Yahoo Finance

Apr 16, 2025

Apr 16, 2025

Schrodinger price target raised to $32 from $30 at KeyBanc - TipRanks

Apr 16, 2025

Apr 15, 2025

Schrodinger’s Karen Akinsanya sells $419,570 in stock By Investing.com - Investing.com South Africa

Apr 15, 2025

Apr 15, 2025

Schrodinger’s Karen Akinsanya sells $419,570 in stock - Investing.com

Apr 15, 2025

Apr 15, 2025

Schrodinger issues statement on FDA phasing out animal testing requirement - TipRanks

Apr 15, 2025

Apr 15, 2025

FDA recent move marks paradigm shift in drug development, boosting Schrödinger (SDGR) and other biotech stocks - Investorsobserver

Apr 15, 2025

Apr 14, 2025

Schrodinger (SDGR) Backs FDA's Initiative to Cut Animal Testing in Drug Development | SDGR Stock News - GuruFocus

Apr 14, 2025

Apr 14, 2025

Schrödinger's Statement Regarding FDA Plan to Phase Out Animal T - GuruFocus

Apr 14, 2025

Apr 14, 2025

Schrödinger backs FDA’s move away from animal testing By Investing.com - Investing.com South Africa

Apr 14, 2025

Apr 14, 2025

Schrodinger to Launch Predictive Toxicology Tool in H2 - marketscreener.com

Apr 14, 2025

Apr 14, 2025

Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs - 01net

Apr 14, 2025

Apr 14, 2025

Schrödinger backs FDA’s move away from animal testing - Investing.com Australia

Apr 14, 2025

Apr 14, 2025

Schrödinger'S Statement Regarding FDA Plan To Phase Out Animal Testing Requirement For Monoclonal Antibodies And Other Drugs - MarketScreener

Apr 14, 2025

Apr 13, 2025

Vanguard Group Inc. Lowers Holdings in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Apr 13, 2025

Apr 12, 2025

Schrödinger Poised For Growth As FDA Shifts Away From Animal Testing (Upgrade) - Seeking Alpha

Apr 12, 2025

Apr 11, 2025

Schrödinger (SDGR) Reveals Promising Preclinical Data for Cancer Inhibitors - GuruFocus

Apr 11, 2025

Apr 11, 2025

Schrodinger Settles Lawsuit Over Director Compensations; Shares Up - MarketScreener

Apr 11, 2025

Apr 11, 2025

Schrödinger (SDGR) Faces Cash Burn Challenges Amid Growth - GuruFocus

Apr 11, 2025

Apr 11, 2025

Schrodinger settles director pay lawsuit, to reform governance By Investing.com - Investing.com South Africa

Apr 11, 2025

Apr 11, 2025

Schrodinger settles director pay lawsuit, to reform governance - Investing.com

Apr 11, 2025

Apr 10, 2025

Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements - Benzinga

Apr 10, 2025

Apr 07, 2025

Schrodinger Stock Hits 52-Week Low at $16.64 Amid Market Challenges - Investing.com

Apr 07, 2025

Apr 07, 2025

Schrödinger, Inc. (NASDAQ:SDGR) Shares Purchased by Massachusetts Financial Services Co. MA - MarketBeat

Apr 07, 2025

Apr 02, 2025

Top 5 AI & Digital Biotech Companies (April 2025) - Securities.io

Apr 02, 2025

Mar 28, 2025

Swiss National Bank Has $2.41 Million Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World

Mar 28, 2025

Mar 27, 2025

Schrödinger (NASDAQ:SDGR) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Mar 27, 2025

Mar 26, 2025

Schrödinger Finally Embraces AI – Is It a Buy? - Nanalyze

Mar 26, 2025

Mar 26, 2025

Schrödinger to Present Preclinical Data at AACR Annual Meeting - 01net

Mar 26, 2025

Mar 26, 2025

Schrödinger to Present at Four Investor Conferences in September - Business Wire

Mar 26, 2025

Mar 23, 2025

(SDGR) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Mar 23, 2025

Mar 20, 2025

Schrodinger Inc (SDGR) Trading Down 1.72% on Mar 21 - GuruFocus.com

Mar 20, 2025

Mar 18, 2025

Schrodinger at KeyBanc Forum: Computational Drug Discovery Focus By Investing.com - Investing.com South Africa

Mar 18, 2025

Mar 18, 2025

Schrodinger at KeyBanc Forum: Computational Drug Discovery Focus - Investing.com India

Mar 18, 2025

Mar 12, 2025

(SDGR) Proactive Strategies - Stock Traders Daily

Mar 12, 2025

Mar 12, 2025

Proficio Capital Partners LLC Purchases Shares of 11,285 Schrödinger, Inc. (NASDAQ:SDGR) - Defense World

Mar 12, 2025

Mar 10, 2025

Schrödinger adds Bridget van Kralingen to board By Investing.com - Investing.com Australia

Mar 10, 2025

Mar 10, 2025

Schrodinger at Leerink Global: Strategic Growth and Challenges - Investing.com India

Mar 10, 2025

Mar 10, 2025

Schrodinger appoints Bridget van Kralingen to board By Investing.com - Investing.com Canada

Mar 10, 2025